Other
24 Authors
- Chen YQ,
- Konrad RJ,
- Tran AP,
- Nakajima K,
- Tu Y,
- Weston TA,
- Nguyen LP,
- Murakami M,
- Tran CM,
- Zhen EY,
- Miyashita K,
- Jung H,
- Yang Y,
- Song W,
- Kim PH,
- Ploug M,
- Xie K,
- Birrane G,
- Fong LG,
- Young SG,
- Tontonoz P,
- Beigneux AP,
- Yu RG,
- Kim JR
| First Author | Yang Y | Year | 2023 |
| Journal | J Clin Invest | Volume | 133 |
| Issue | 23 | PubMed ID | 37824203 |
| Mgi Jnum | J:343428 | Mgi Id | MGI:7563793 |
| Doi | 10.1172/JCI172600 | Citation | Yang Y, et al. (2023) Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen. J Clin Invest 133(23) |
| abstractText | Why apolipoprotein AV (APOA5) deficiency causes hypertriglyceridemia has remained unclear, but we have suspected that the underlying cause is reduced amounts of lipoprotein lipase (LPL) in capillaries. By routine immunohistochemistry, we observed reduced LPL staining of heart and brown adipose tissue (BAT) capillaries in Apoa5-/- mice. Also, after an intravenous injection of LPL-, CD31-, and GPIHBP1-specific mAbs, the binding of LPL Abs to heart and BAT capillaries (relative to CD31 or GPIHBP1 Abs) was reduced in Apoa5-/- mice. LPL levels in the postheparin plasma were also lower in Apoa5-/- mice. We suspected that a recent biochemical observation - that APOA5 binds to the ANGPTL3/8 complex and suppresses its capacity to inhibit LPL catalytic activity - could be related to the low intracapillary LPL levels in Apoa5-/- mice. We showed that an ANGPTL3/8-specific mAb (IBA490) and APOA5 normalized plasma triglyceride (TG) levels and intracapillary LPL levels in Apoa5-/- mice. We also showed that ANGPTL3/8 detached LPL from heparan sulfate proteoglycans and GPIHBP1 on the surface of cells and that the LPL detachment was blocked by IBA490 and APOA5. Our studies explain the hypertriglyceridemia in Apoa5-/- mice and further illuminate the molecular mechanisms that regulate plasma TG metabolism. |
